A concise review on factors influencing the hematopoietic stem cell transplantation main outcomes

As a curative procedure, hematopoietic stemcell transplantation (HSCT) is an approved treatment for many malignant orbenign hematologic and non‐hematologic diseases. There are different outcomes of HSCT, as well as several parameters influencing these outcomes.

[1]  Jin Zhou,et al.  [Application of Conditioning Regimen with Busulfan and Cyclophosphamide in Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma]. , 2021, Zhongguo shi yan xue ye xue za zhi.

[2]  A. Santoro,et al.  Haploidentical Stem Cell Transplantation in Lymphomas—Expectations and Pitfalls , 2020, Journal of clinical medicine.

[3]  B. Simões,et al.  Brazilian Nutritional Consensus in Hematopoietic Stem Cell Transplantation: Adults , 2019, Einstein.

[4]  M. Martelli,et al.  The Evolution of T Cell Depleted Haploidentical Transplantation , 2019, Front. Immunol..

[5]  P. Vyas,et al.  The Graft-Versus-Leukemia Effect in AML , 2019, Front. Oncol..

[6]  S. Montoto,et al.  Outcomes of allogeneic haematopoietic stem cell transplantation from HLA-matched and alternative donors: a European Society for Blood and Marrow Transplantation registry retrospective analysis. , 2019, The Lancet. Haematology.

[7]  E. Forsberg,et al.  Viagra Enables Efficient, Single-Day Hematopoietic Stem Cell Mobilization , 2019, Stem cell reports.

[8]  V. Rocha,et al.  The impact of pretransplant malnutrition on allogeneic hematopoietic stem cell transplantation outcomes. , 2019, Clinical nutrition ESPEN.

[9]  D. Fürst,et al.  HLA Matching in Unrelated Stem Cell Transplantation up to Date , 2019, Transfusion Medicine and Hemotherapy.

[10]  Zhidong Wang,et al.  Efficacy and safety of plerixafor for hematopoietic stem cell mobilization for autologous transplantation in patients with non-Hodgkin lymphoma and multiple myeloma: A systematic review and meta-analysis , 2019, Experimental and therapeutic medicine.

[11]  H. Kolb,et al.  Emerging Role of Mesenchymal Stromal Cell-Derived Extracellular Vesicles in Pathogenesis of Haematological Malignancies , 2019, Stem cells international.

[12]  F. P. Santos,et al.  Brazilian Nutritional Consensus in Hematopoietic Stem Cell Transplantation: Elderly , 2019, Einstein.

[13]  T. Gooley,et al.  Impact of Body Mass Index on Outcomes of Hematopoietic Stem Cell Transplantation in Adults. , 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[14]  R. Hassan,et al.  Autologous Peripheral Blood Stem Cell Transplantation Among Lymphoproliferative Disease Patients: Factors Influencing Engraftment , 2019, Oman medical journal.

[15]  T. Spitzer,et al.  Peripheral Blood or Bone Marrow Stem Cells? Practical Considerations in Hematopoietic Stem Cell Transplantation. , 2019, Transfusion medicine reviews.

[16]  Xiao-jun Huang,et al.  Strategies for Enhancing and Preserving Anti-leukemia Effects Without Aggravating Graft-Versus-Host Disease , 2018, Front. Immunol..

[17]  J. Dipersio,et al.  Conditioning for Hematopoietic Stem Cell Transplantation Using Antibody-Drug Conjugate Targeting CD45 Permits Engraftment across Immunologic Barriers , 2018, Blood.

[18]  O. G. Best,et al.  DNA Damage in Haemopoeitic Stem Cells Impacts on Neutrophil and Platelet Engraftment Following Autologous Transplantation , 2018, Blood.

[19]  Q. Shu,et al.  Mesenchymal stem cell-derived extracellular vesicles affect disease outcomes via transfer of microRNAs , 2018, Stem Cell Research & Therapy.

[20]  S. Crippa,et al.  Mesenchymal Stromal Cells: Role in the BM Niche and in the Support of Hematopoietic Stem Cell Transplantation , 2018, HemaSphere.

[21]  Hisashi Yamamoto,et al.  No post-transplant pure red cell aplasia development in 106 major ABO incompatible cord blood transplantation , 2018, Bone Marrow Transplantation.

[22]  Yi Zheng,et al.  A non-myeloablative conditioning approach for long-term engraftment of human and mouse hematopoietic stem cells , 2018, Leukemia.

[23]  F. Demirkan,et al.  Does Reinfusion of Stem Cell Products on Multiple Days Affect Engraftment? , 2018, Turkish journal of haematology : official journal of Turkish Society of Haematology.

[24]  G. Falco,et al.  Extracellular Vesicles: A New Prospective in Crosstalk between Microenvironment and Stem Cells in Hematological Malignancies , 2018, Stem cells international.

[25]  J. Tabibian,et al.  In-patient outcomes of Hematopoietic Stem Cell Transplantation in Patients with Immune Mediated Inflammatory Diseases: A Nationwide Study , 2018, Scientific Reports.

[26]  J. Wagner,et al.  Delayed immune reconstitution after allogeneic transplantation increases the risks of mortality and chronic GVHD. , 2018, Blood advances.

[27]  M. Andreani,et al.  Major Histocompatibility Complex and Hematopoietic Stem Cell Transplantation: Beyond the Classical HLA Polymorphism , 2018, International journal of molecular sciences.

[28]  A. Babić,et al.  The European Blood and Marrow Transplantation Textbook for Nurses , 2018, Springer International Publishing.

[29]  D. Greenfield,et al.  Late Effects and Long-Term Follow-Up , 2018 .

[30]  Masumi Ueda.  Body composition assessment in hematopoietic stem cell transplantation☆ , 2017, Revista brasileira de hematologia e hemoterapia.

[31]  A. Nademanee,et al.  Engraftment and outcomes following autologous stem cell transplantation in Hodgkin lymphoma patients mobilized with plerixafor , 2017, Hematological oncology.

[32]  T. Jaffredo,et al.  Extracellular vesicles of stromal origin target and support hematopoietic stem and progenitor cells , 2017, The Journal of cell biology.

[33]  H. Abdel-Azim,et al.  Role of αβ T Cell Depletion in Prevention of Graft versus Host Disease , 2017, Biomedicines.

[34]  Irene Riezzo,et al.  Donor Selection for Allogenic Hemopoietic Stem Cell Transplantation: Clinical and Ethical Considerations , 2017, Stem cells international.

[35]  Jin Seok Kim.  Hematopoietic stem cell mobilization: current status and future perspective , 2017, Blood research.

[36]  I. Laurenzana,et al.  Mesenchymal Stem Cell Derived Extracellular Vesicles: A Role in Hematopoietic Transplantation? , 2017, International journal of molecular sciences.

[37]  G. Caocci,et al.  Bone Marrow Homing and Engraftment Defects of Human Hematopoietic Stem and Progenitor Cells , 2017, Mediterranean journal of hematology and infectious diseases.

[38]  K. Alimoghaddam,et al.  ABO Incompatibility and Hematopoietic Stem Cell Transplantation Outcomes , 2017, International journal of hematology-oncology and stem cell research.

[39]  P. Ljungman,et al.  Impact of Pretransplantation Indices in Hematopoietic Stem Cell Transplantation: Knowledge of Center-Specific Outcome Data Is Pivotal before Making Index-Based Decisions. , 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[40]  L. Lamb,et al.  Ex vivo T-cell depletion in allogeneic hematopoietic stem cell transplant: past, present and future , 2017, Bone Marrow Transplantation.

[41]  H. Nakasone,et al.  Impact of total body irradiation on successful neutrophil engraftment in unrelated bone marrow or cord blood transplantation , 2017, American journal of hematology.

[42]  J. Partanen,et al.  Graft Immune Cell Composition Associates with Clinical Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Patients with AML , 2016, Front. Immunol..

[43]  R. Emmons,et al.  Exercise as an Adjuvant Therapy for Hematopoietic Stem Cell Mobilization , 2016, Stem cells international.

[44]  T. Cluzeau,et al.  Risk factors and outcome of graft failure after HLA matched and mismatched unrelated donor hematopoietic stem cell transplantation: a study on behalf of SFGM-TC and SFHI , 2016, Bone Marrow Transplantation.

[45]  M. Labopin,et al.  Is there a stronger graft-versus-leukemia effect using HLA-haploidentical donors compared with HLA-identical siblings? , 2016, Leukemia.

[46]  I. Laurenzana,et al.  MiRNAs and piRNAs from bone marrow mesenchymal stem cell extracellular vesicles induce cell survival and inhibit cell differentiation of cord blood hematopoietic stem cells: a new insight in transplantation , 2015, Oncotarget.

[47]  Nina Worel,et al.  ABO-Mismatched Allogeneic Hematopoietic Stem Cell Transplantation , 2015, Transfusion Medicine and Hemotherapy.

[48]  J. O'connor,et al.  Mesenchymal stromal cells enhance the engraftment of hematopoietic stem cells in an autologous mouse transplantation model , 2015, Stem Cell Research & Therapy.

[49]  M. Pasquini,et al.  Primary Graft Failure after Myeloablative Allogeneic Hematopoietic Cell Transplantation for Hematologic Malignancies , 2015, Leukemia.

[50]  D. Porter,et al.  Reduced-intensity conditioned allogeneic SCT in adults with AML , 2015, Bone Marrow Transplantation.

[51]  R. Nelson,et al.  Cyclophosphamide/fludarabine nonmyeloablative allotransplant for acute myeloid leukemia , 2015, American journal of hematology.

[52]  L. Xu,et al.  Chronic GVHD induced GVL effect after unmanipulated haploidentical hematopoietic SCT for AML and myelodysplastic syndrome , 2015, Bone Marrow Transplantation.

[53]  M. Angelopoulou,et al.  New Insights in the Mobilization of Hematopoietic Stem Cells in Lymphoma and Multiple Myeloma Patients , 2014, BioMed research international.

[54]  J. Antin,et al.  Hematopoietic stem cell transplantation donor sources in the 21st century: choosing the ideal donor when a perfect match does not exist. , 2014, Blood.

[55]  Yonghua Li,et al.  Risk-Factor Analysis of Poor Graft Function after Allogeneic Hematopoietic Stem Cell Transplantation , 2014, International journal of medical sciences.

[56]  F. Locatelli,et al.  Current and future approaches to treat graft failure after allogeneic hematopoietic stem cell transplantation , 2014, Expert opinion on pharmacotherapy.

[57]  M. Tombuloğlu,et al.  Risk factors for a poor hematopoietic stem cell mobilization. , 2013, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.

[58]  U. Siekiera,et al.  The Influence Of Anti-HLA Antibodies On Engraftment and Donor’s Chimerism Following Allogeneic Hematopoietic Stem Cell Transplantation From HLA-Mismatched Unrelated Donors , 2013 .

[59]  K. Schwarz,et al.  High-resolution HLA matching in hematopoietic stem cell transplantation: a retrospective collaborative analysis. , 2013, Blood.

[60]  E. Gehrie,et al.  Clinical guide to ABO-incompatible allogeneic stem cell transplantation. , 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[61]  J. Kanda.  Effect of HLA mismatch on acute graft-versus-host disease , 2013, International Journal of Hematology.

[62]  Y. Shoenfeld,et al.  Autoimmunity: From Bench to Bedside [Internet] , 2013 .

[63]  J. Wiskemann.  Exercise in the setting of hematopoietic stem cell transplantation , 2013, European Review of Aging and Physical Activity.

[64]  J. Seo,et al.  Role of HLA in Hematopoietic Stem Cell Transplantation , 2012, Bone marrow research.

[65]  F. Altuntaş,et al.  What Is the Most Appropriate Source for Hematopoietic Stem Cell Transplantation? Peripheral Stem Cell/Bone Marrow/Cord Blood , 2012, Bone marrow research.

[66]  G. Specchia,et al.  CD3+/Tregs ratio in donor grafts is linked to acute graft-versus-host disease and immunologic recovery after allogeneic peripheral blood stem cell transplantation. , 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[67]  Liuyan Jiang,et al.  Hematopoietic stem cells from poor and good mobilizers are qualitatively equivalent , 2012, Transfusion.

[68]  M. Testi,et al.  Higher CD3+ and CD34+ cell doses in the graft increase the incidence of acute GVHD in children receiving BMT for thalassemia , 2012, Bone Marrow Transplantation.

[69]  E. Vellenga,et al.  Influence of Different Dosages of Cyclophosphamide on Stem Cell Mobilization and Engraftment In Newly Diagnosed Multiple Myeloma Patients Treated with a Thalidomide Containing Regimen , 2010 .

[70]  R. Iyer,et al.  Outcome of hematopoietic cell transplantation in children with sickle cell disease, a single center's experience , 2010, Bone Marrow Transplantation.

[71]  H. Goldschmidt,et al.  Poor mobilization of hematopoietic stem cells-definitions, incidence, risk factors, and impact on outcome of autologous transplantation. , 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[72]  A. El-Osta,et al.  γH2AX: a sensitive molecular marker of DNA damage and repair , 2010, Leukemia.

[73]  H. Messner,et al.  Mechanisms and Treatment of Graft Failure , 2009 .

[74]  D. Benvegnú,et al.  Successful Hematopoietic Stem Cell Transplantation (hsct), Both Autologous and Allogeneic, Requires a Rapid and Durable Engraftment, with Neutrophil (>500/μl) and Platelet (>20,000/ Μl) Reconstitution. Factors Influencing Engraftment after Autolo- Gous or Allogeneic Hsct Were Investigated in 65 Pati , 2022 .

[75]  M. Gordon.  Allogeneic Marrow Stem-Cell Transplantation From Human Leukocyte Antigen–Identical Siblings Versus Human Leukocyte Antigen–Alleic–Matched Unrelated Donors (10/10) in Patients With Standard-Risk Hematologic Malignancy: A Prospective Study From the French Society of Bone Marrow Transplantation and Cel , 2008 .

[76]  R. Fonseca,et al.  Impact of lenalidomide therapy on stem cell mobilization and engraftment post-peripheral blood stem cell transplantation in patients with newly diagnosed myeloma , 2007, Leukemia.

[77]  P. Ljungman,et al.  Transplantation of mesenchymal stem cells to enhance engraftment of hematopoietic stem cells , 2007, Leukemia.

[78]  L. Akard,et al.  Prediction of engraftment after autologous peripheral blood progenitor cell transplantation: CD34, colony‐forming unit–granulocyte‐macrophage, or both? , 2007, Transfusion.

[79]  S. Nakao,et al.  Immature platelet fraction for prediction of platelet engraftment after allogeneic stem cell transplantation , 2007, Bone Marrow Transplantation.

[80]  J. Bourhis,et al.  Allogeneic marrow stem-cell transplantation from human leukocyte antigen-identical siblings versus human leukocyte antigen-allelic-matched unrelated donors (10/10) in patients with standard-risk hematologic malignancy: a prospective study from the French Society of Bone Marrow Transplantation and Ce , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[81]  G. Specchia,et al.  Early and Long-Term Engraftment after Autologous Peripheral Stem Cell Transplantation in Acute Myeloid Leukemia Patients , 2006, Acta Haematologica.

[82]  Mark Ende,et al.  Hematopoietic stem-cell transplantation. , 2006, The New England journal of medicine.

[83]  A. Gratwohl,et al.  Consequences of ABO incompatibility in allogeneic hematopoietic stem cell transplantation , 2002, Bone Marrow Transplantation.

[84]  S. Glück,et al.  Predictive factors for long-term engraftment of autologous blood stem cells , 2000, Bone Marrow Transplantation.